Best practice: Gross examination and sampling of surgical specimens from the urinary bladder

Journal of Clinical Pathology

Volumn 63, Issue 6, 2010, Pages 475-479

  Chandra, Ashish ^a   Griffiths, David ^b   McWilliam, Lorna J ^c  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE;

BLADDER BIOPSY; BLADDER TUMOR; CYSTECTOMY; FROZEN SECTION; LYMPH NODE; PRIORITY JOURNAL; PROSTATE; QUALITY CONTROL; REVIEW; URINE CYTOLOGY; UTERUS; VAGINA;

BIOPSY; CYSTECTOMY; HUMANS; PROGNOSIS; QUALITY ASSURANCE, HEALTH CARE; SPECIMEN HANDLING; URINARY BLADDER; URINARY BLADDER DISEASES; URINARY BLADDER NEOPLASMS;

EID: 77953700007     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.071191     Document Type: Review

References (22)

1. Improving Outcomes in Urological Cancers. The Manual. Guidance on cancer services. In: Excellence NIoC, 2002. http://www.nice.org.uk.
2. European Association of Urology (EAU) guidelines 2007.
3. Harnden P, Eardley I, Joyce AD, et al. Cytokeratin 20 as an objective marker of urothelial dysplasia. Br J Urol 1996;78:870-5.
4. McKenney JK, Desai S, Cohen C, et al. Discriminatory immunohistochemical staining of urothelial carcinoma in situ and non-neoplastic urothelium. An analysis of cytokeratin 20, p53 and CD44 antigens. Am J Surg Pathol 2001;25:1074-8.
5. Paner GP, Shen SS, Lapetino S, et al. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol 2009;33:91-8.
6. Wells M. Guidelines on inter-departmental dispatch and funding of histopathology referrals. London: The Royal College of Pathologists, 2009.
7. Lester SC. Genitourinary specimens. In Manual of surgical pathology, 2nd edn. Philadelphia: Elsevier, 2006:386-94.
8. Sanderson KM, Cai J, Miranda G, et al. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup. J Urol 2007;177:2088-94.
9. Bennett VS, Varma M, Bailey DM. Guidelines for the macroscopic processing of radical prostatectomy and pelvic lymphadenectomy specimens. J Clin Path 2008;61:713-21.
10. Raj GV, Tal R, Vickers A, et al. significance of intraoperative ureteral evaluation at radical cystectomy for urothelial cancer. Cancer 2006;107:2167-72.
11. Lee SE, Byun SS, Hong SK, et al. Significance of cancer involvement at the ureteral margin detected on routine frozen section analysis during radical cystectomy. Urol Int 2006;77:13-17.
12. Donat SM. Argument against frozen section analysis of distal ureters in transitional cell bladder cancer. Nat Clin Pract Urol 2008;5:538-9.
13. Harnden P, Ball R, Freeman A. Dataset for tumours of the urinary collecting system. London: Royal College of Pathologists, 2007.
14. Buscarini M, Jospehson DY, Stein JP. Lymphadenectomy in bladder cancer: a review. Urol Int 2007;79:191-9.
15. Huang WC, Bochner BH. Current status of establishing standards for lymphadenectomy in the treatment of bladder cancer. Curr Opin Urol 2005;15:315-19.
16. Stein JP, Penson DF, Cai J, et al. Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol 2007;177:876-81.
17. Honma I, Masumori M, Sato E, et al. Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings in patients with bladder cancer- analysis of role of pelvic lymph node dissection. Urology 2006;68:543-8.
18. Guru KA, Sternberg K, Wilding GE, et al. The lymph node yield during robot-assisted radical cystectomy. BJU Int 2008;102:231-4.
19. Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumours. International classification of tumours, No 10. Geneva: WHO, 1973.
20. Epstein JI, Amin MB, Reuter VR, et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 1998;22:1435-48.
21. Murphy WM, Grignon DJ, Perlman EJ. Tumours of the urinary bladder. AFIP Atlas of tumour pathology (Series 4) 2004.
22. Benjamin A. Audit: how to do it in practice. BMJ 2008;336:1241-5.